Subscribe


PD breaking news – Medicines Regulation inquiry calls for comp meds submissions

Questions about efficacy testing, non-compliance deterrents posed. 

The panel conducting the Review of Medicines and Medical Devices Regulation has called for submissions from stakeholders regarding regulation of complementary medicines.

The panel, headed by Emeritus Professor Lloyd Sansom and announced last year (PD 27 Oct 14), released an addendum to its discussion paper today dealing with complementary medicines.

The chapter, which was flagged at the time of the Review’s announcement, asks various questions of stakeholders, including whether an ingredient should only be considered to have been ‘approved’ by an overseas regulator if it had been subjected to assessment, and if so, whether this assessment should include quality, safety and efficacy.

The document said while Canadian regulators undertook pre-market evaluation of ingredients in complementary medicines for quality, safety and efficacy, the US Food and Drug Administration only require notification of a new ingredient and demonstration of a reasonable expectation of safety for use in a dietary supplement.

“As such, ‘approval’ of a new ingredient in Canada means something quite different than ‘approval’ of a new ingredient in the US.

“In Australia, the TGA assesses quality and safety of a new ingredient, but does not undertake an assessment of efficacy.”

Other questions asked of stakeholders include whether Australia should adopt approval of ingredients by ‘trusted’ overseas regulators, whether the current regulatory regime for complementary medicines in Australia is commensurate with the risk posed by products, and whether low-risk complementary medicines should be regulated as general consumer goods, rather than having to be listed on the Australian Register of Therapeutic Goods.

The chapter also asks whether current legislation provided sufficient deterrents to prevent sponsors “knowingly listing non-compliant complementary medicines” on the Register, citing the fact that sponsors could request a product be removed from the Register if it is subjected to a review by the Therapeutic Goods Administration, and re-list it at a later date.

Submissions on the addendum are due by 08 Apr.

For more, see Monday’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 20 Feb 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

19 Jan

Dispensary Corner 19 Jan 18 - IT MAKES perfect sense for the operation ...


19 Jan

PBA data released - THE Pharmacy Board of Australia has released ...


19 Jan

‘Out of pocket pain’ - THE Consumers Health Forum (CHF) has announced ...


19 Jan

Cannabis PBS listing? - VICTORIAN Health Minister Jill Hennessy has confirmed ...


19 Jan

Industrial hemp meet - THE Australian Industrial Hemp Conference is calling ...


19 Jan

S3 advertising permitted - THE Therapeutic Goods Administration has confirmed that ...


19 Jan

Codeine story ‘misleading’ - WHILE the rescheduling of products containing codeine ...


18 Jan

Travel Specials 18 Jan 18 - VIEW & Verandah Sale by Holland America ...


18 Jan

Dispensary Corner 18 Jan 18 - NEWLYWEDS from Northern Ireland have wasted no ...


18 Jan

CW float speculation - THE owners of Chemist Warehouse may be ...


18 Jan

Life-Long Learning - THE Australian Pharmacy Council has announced the ...


18 Jan

FIP Glasgow regos - REGISTRATIONS have opened for the 78th International ...


18 Jan

Vic Guild election - THE Victorian Branch of the Pharmacy Guild ...


18 Jan

Blood clot warning - A DRUG that women use as a ...


18 Jan

TGA reformats PIs - EFFECTIVE 01 Jan this year, all product ...


18 Jan

PBA competency standards - THE Pharmacy Practitioner Development Committee (PPDC) met ...


18 Jan

The eyes have it - RESEARCH conducted by the University of Queensland ...


18 Jan

Pharmacy role in National Pain Plan - PHARMACISTS have been identified as key advisors ...


18 Jan

SHPA affirms codeine move - THE Society of Hospital Pharmacists of Australia ...


17 Jan

Ibuprofen Double Strength 400 - ARROW Pharmaceuticals announces the launch of Chemists' ...



Show Pharmacy Daily items by month: